Exact Sciences Corp (NASDAQ:EXAS)

146.00
Delayed Data
As of Jan 15
 -1.29 / -0.88%
Today’s Change
35.25
Today|||52-Week Range
152.68
+10.20%
Year-to-Date
Forget Snowflake! Buy This Ultra-High-Growth Stock
Jan 15 / MotleyFool.com - Paid Partner Content
Exact Sciences (EXAS) Soars: Stock Adds 9.8% in Session
Jan 12 / Zacks.com - Paid Partner Content
Exact Sciences (EXAS) Posts Solid Preliminary Q4 Testing Revenues
Jan 14 / Zacks.com - Paid Partner Content
Why Exact Sciences Stock Is Soaring Today
Jan 11 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close147.29
Today’s open146.13
Day’s range142.52 - 149.57
Volume124,538
Average volume (3 months)2,009,431
Market cap$23.2B
Data as of 3:59pm ET, 01/15/2021

Growth & Valuation

Earnings growth (last year)+55.35%
Earnings growth (this year)-377.32%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+92.82%
P/E ratioNM
Price/Sales13.85
Price/Book9.38

Competitors

----
BMRNBiomarin Pharmaceuti...+1.56+1.92%
ZLABZai Lab Ltd+6.97+4.25%
CRSPCRISPR Therapeutics ...-9.99-4.76%
Data as of 5:07pm ET, 01/15/2021

Financials

Next reporting dateFebruary 25, 2021
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$876.3M
Annual profit (last year)-$84.0M
Net profit margin-9.59%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Madison, Wisconsin

Forecasts